In particular, in SKBR3 breast cancer cell line, quercetin treatment resulted in a suppression of tyrosine kinase activity and in a reduction of ErbB2/neu protein level as well as in a dephosphorylation of phosphatidylinositol-3-kinase (PI3K) and Akt [50]. The gene discussed is AKT1; the disease is breast carcinoma.